Calculated low-density lipoprotein cholesterol remains a viable and important test for screening and targeting therapy
-
Ntei Abudu
Abstract
Background: Most clinical laboratories use calculated (C) low-density lipoprotein cholesterol (LDL-C) for measurement. Some studies have questioned the linearity of CLDL-C in the clinically useful low range. Moreover, it is generally believed that calculation leads to poor precision such that variation in CLDL-C is greater than the 4% guideline since the calculation is dependent on three primary variables. Actually, the degree of variability of a calculated value will be small if the variability of each primary value is small as compared to its contribution to the calculated value. When LDL-C is low, high-density lipoprotein cholesterol (HDL-C), that has poorer precision, becomes more important in defining the precision of CLDL-C. New homogeneous (direct) HDL-C (dHDL) methods show better precision than the older heterogeneous methods. We hypothesized that a direct homogeneous HDL-C method would substantially improve the low range precision of LDL-C as compared to older heterogeneous HDL-C methods.
Methods: We compared CLDL-C to a standardized electrophoretic method that shows very high precision. We also compared the precision of CLDL-C calculated using a homogeneous dHDL and a heterogeneous indirect method.
Results: We found good linearity for CLDL-C down to 500 mg/L (×0.002586). The main source of CLDL-C variation was HDL-C. Precision was within guidelines when the dHDL method was used. Using our automated methods for lipoprotein lipids, assuming our reference method is accurate, the formula that calculated CLDL-C (mg/dL) using triglyceride (mg/dL) (×0.001129) ×0.2 suggested by some gave more accurate results than the formula using triglyceride (mg/dL) ×0.16 suggested by others.
Conclusions: Given the potential for CLDL-C to meet the precision guidelines, until direct LDL-C methods can be refined, CLDL-C should continue to be the primary test used for assessing LDL-C clinically. Standardized testing for CLDL-C for manufacturers should be available so that the formula used for each instrument can provide well-defined accuracy.
Clin Chem Lab Med 2007;45:1319–25.
©2007 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Atrial natriuretic peptide and related peptides
- The −374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients
- Biochemical properties of endogenous presenilin 1 and presenilin 2 in cultured human B-lymphocytes
- CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population
- Preservation of RNA for functional analysis of separated alleles in yeast: comparison of snap-frozen and RNALater® solid tissue storage methods
- Mother-child double incompatibility at vWA and D5S818 loci in paternity testing
- Matrix metalloprotease-2 and -9 concentration and activity in serum and culture medium samples: a methodological reappraisal
- Are changes in blood-ethanol concentration during storage analytically significant? Importance of method imprecision
- Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry
- The soluble transferrin receptor reflects tumor load in chronic lymphocytic leukemia
- Calculated low-density lipoprotein cholesterol remains a viable and important test for screening and targeting therapy
- Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia
- Differentiating transudative from exudative pleural effusion: should we measure effusion cholesterol dehydrogenase?
- Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort
- Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology
- Use of a solid-phase extraction with radioimmunoassay to identify the proportional bias of clinical B-type natriuretic peptide immunoassay: the impact of plasma matrix and antibody multispecificity
- High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction
- Methylprednisolone, cortisol and the cell-mediated immune response in children after ventricular septal defect repair
- Standardization of γ-glutamyltransferase assays by intermethod calibration. Effect on determining common reference limits
- The effect of endurance exercise-induced lactacidosis on biochemical markers of bone turnover
- Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation
- Diagnostic usefulness of a third-generation anti-cyclic citrulline antibody test in patients with recent-onset polyarthritis
- Clinical significance of the laboratory determination of low serum copper in adults
- National survey on critical values reporting in a cohort of Italian laboratories
- Influence of haemodialysis on the NT-proBNP plasma concentration
- C–588T polymorphism of the human glutamate-cysteine ligase modifier subunit gene is not associated with the risk and extent of ischemic heart disease in a German cohort
- Has homocysteine shrunk?
Artikel in diesem Heft
- Atrial natriuretic peptide and related peptides
- The −374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients
- Biochemical properties of endogenous presenilin 1 and presenilin 2 in cultured human B-lymphocytes
- CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population
- Preservation of RNA for functional analysis of separated alleles in yeast: comparison of snap-frozen and RNALater® solid tissue storage methods
- Mother-child double incompatibility at vWA and D5S818 loci in paternity testing
- Matrix metalloprotease-2 and -9 concentration and activity in serum and culture medium samples: a methodological reappraisal
- Are changes in blood-ethanol concentration during storage analytically significant? Importance of method imprecision
- Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry
- The soluble transferrin receptor reflects tumor load in chronic lymphocytic leukemia
- Calculated low-density lipoprotein cholesterol remains a viable and important test for screening and targeting therapy
- Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia
- Differentiating transudative from exudative pleural effusion: should we measure effusion cholesterol dehydrogenase?
- Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort
- Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology
- Use of a solid-phase extraction with radioimmunoassay to identify the proportional bias of clinical B-type natriuretic peptide immunoassay: the impact of plasma matrix and antibody multispecificity
- High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction
- Methylprednisolone, cortisol and the cell-mediated immune response in children after ventricular septal defect repair
- Standardization of γ-glutamyltransferase assays by intermethod calibration. Effect on determining common reference limits
- The effect of endurance exercise-induced lactacidosis on biochemical markers of bone turnover
- Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation
- Diagnostic usefulness of a third-generation anti-cyclic citrulline antibody test in patients with recent-onset polyarthritis
- Clinical significance of the laboratory determination of low serum copper in adults
- National survey on critical values reporting in a cohort of Italian laboratories
- Influence of haemodialysis on the NT-proBNP plasma concentration
- C–588T polymorphism of the human glutamate-cysteine ligase modifier subunit gene is not associated with the risk and extent of ischemic heart disease in a German cohort
- Has homocysteine shrunk?
